AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
MAPPING OF GENOMIC T(2-5)(P23-Q35) BREAK POINTS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA BY SEQUENCING LONG-RANGE PCR PRODUCTS
Authors: LUTHRA R PUGH WC WAASDORP M MORRIS W CABANILLAS F CHAN PK SARRIS AH
Citation: R. Luthra et al., MAPPING OF GENOMIC T(2-5)(P23-Q35) BREAK POINTS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA BY SEQUENCING LONG-RANGE PCR PRODUCTS, Hematopathology and molecular hematology, 11(3-4), 1998, pp. 173-183
GENOMIC DNA AMPLIFICATION AND THE DETECTION OF T(2-5)(P23-Q35) IN LYMPHOID NEOPLASMS
Authors: SARRIS AH LUTHRA R CABANILLAS F MORRIS SW PUGH WC
Citation: Ah. Sarris et al., GENOMIC DNA AMPLIFICATION AND THE DETECTION OF T(2-5)(P23-Q35) IN LYMPHOID NEOPLASMS, Leukemia & lymphoma, 29(5-6), 1998, pp. 507-514
TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10
Authors: DALIANI D ULMER RA JACKOW C PUGH W GANSBACHER B CABANILLAS F DUVIC M SARRIS AH
Citation: D. Daliani et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10, Leukemia & lymphoma, 29(3-4), 1998, pp. 315
USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS
Authors: ROMAGUERA JE DIAZPAVON JR CARIAS L HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA SARRIS AH YOUNES A PRETI A BACHIER C LLERENA E CABANILLAS F
Citation: Je. Romaguera et al., USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS, Leukemia & lymphoma, 28(3-4), 1998, pp. 295-306
T(2-5) AND FAILURE-FREE SURVIVAL (FFS) OF DOXORUBICIN-TREATED ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
Authors: HERLING M PUGH W MORRIS SW FALINI B CABANILLAS F SARRIS AH
Citation: M. Herling et al., T(2-5) AND FAILURE-FREE SURVIVAL (FFS) OF DOXORUBICIN-TREATED ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL), British Journal of Haematology, 102(1), 1998, pp. 123-123
A 5' EXONUCLEASE-BASED REAL-TIME PCR (ERTPCR) ASSAY FOR DETECTION OF T(14-18) (Q32-Q21) IN FOLLICULAR LYMPHOMA
Authors: LUTHRA R MCBRIDE JA CABANILLAS F SARRIS AH
Citation: R. Luthra et al., A 5' EXONUCLEASE-BASED REAL-TIME PCR (ERTPCR) ASSAY FOR DETECTION OF T(14-18) (Q32-Q21) IN FOLLICULAR LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 144-145
MCP-1, NOT MIP-1-ALPHA, IS THE ENDOGENOUS CHEMOKINE THAT COOPERATES WITH TGF-BETA TO INHIBIT THE CYCLING OF PRIMITIVE NORMAL BUT NOT LEUKEMIC (CML) PROGENITORS IN LONG-TERM HUMAN MARROW CULTURES
Authors: CASHMAN JD EAVES CJ SARRIS AH EAVES AC
Citation: Jd. Cashman et al., MCP-1, NOT MIP-1-ALPHA, IS THE ENDOGENOUS CHEMOKINE THAT COOPERATES WITH TGF-BETA TO INHIBIT THE CYCLING OF PRIMITIVE NORMAL BUT NOT LEUKEMIC (CML) PROGENITORS IN LONG-TERM HUMAN MARROW CULTURES, Blood, 92(7), 1998, pp. 2338-2344
THE CLINICAL-SIGNIFICANCE OF MOLECULAR RESPONSE IN INDOLENT FOLLICULAR LYMPHOMAS
Authors: LOPEZGUILLERMO A CABANILLAS F MCLAUGHLIN P SMITH T HAGEMEISTER F RODRIGUEZ MA ROMAGUERA JE YOUNES A SARRIS AH PRETI HA PUGH W LEE MS
Citation: A. Lopezguillermo et al., THE CLINICAL-SIGNIFICANCE OF MOLECULAR RESPONSE IN INDOLENT FOLLICULAR LYMPHOMAS, Blood, 91(8), 1998, pp. 2955-2960
INTERFERON-INDUCIBLE PROTEIN-10 AS A POSSIBLE FACTOR IN THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS
Authors: SARRIS AH DALIANI D ULMER R CROW M BROXMEYER HE REISS M KARASAVVAS N ZELENETZ AD PUGH W CABANILLAS F DEISSEROTH AB DUVIC M
Citation: Ah. Sarris et al., INTERFERON-INDUCIBLE PROTEIN-10 AS A POSSIBLE FACTOR IN THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS, Clinical cancer research, 3(2), 1997, pp. 169-177
PRIMARY PAROTID LYMPHOMA - THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX ON OUTCOME
Authors: SARRIS AH PAPADIMITRAKOPOULOU V DIMOPOULOS MA SMITH T PUGH W HA CS MCLAUGHLIN P CALLENDER D COX J CABANILLAS F
Citation: Ah. Sarris et al., PRIMARY PAROTID LYMPHOMA - THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX ON OUTCOME, Leukemia & lymphoma, 26(1-2), 1997, pp. 49-56
PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: YOUNES A RODRIGUEZ MA MCLAUGHLIN P NORTH L SARRIS AH PATE O HAGEMEISTER FB ROMAGUERA J PRETI A BACHIER C CABANILLAS F
Citation: A. Younes et al., PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 77-82
LONG-RANGE AMPLIFICATION OF GENOMIC DNA DETECTS THE T(2-5)(P23-Q35) IN ANAPLASTIC LARGE-CELL LYMPHOMA, BUT NOT IN OTHER NON-HODGKINS-LYMPHOMAS, HODGKINS-DISEASE, OR LYMPHOMATOID PAPULOSIS
Authors: SARRIS AH LUTHRA R PAPADIMITRACOPOULOU V WAASDORP M DIMOPOULOS MA MCBRIDE JA CABANILLAS F DUVIC M DEISSEROTH A MORRIS SW PUGH WC
Citation: Ah. Sarris et al., LONG-RANGE AMPLIFICATION OF GENOMIC DNA DETECTS THE T(2-5)(P23-Q35) IN ANAPLASTIC LARGE-CELL LYMPHOMA, BUT NOT IN OTHER NON-HODGKINS-LYMPHOMAS, HODGKINS-DISEASE, OR LYMPHOMATOID PAPULOSIS, Annals of oncology, 8, 1997, pp. 59-63
PROGNOSTIC FACTORS IN EARLY-STAGE HODGKINS-DISEASE
Authors: SARRIS AH
Citation: Ah. Sarris, PROGNOSTIC FACTORS IN EARLY-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(1), 1997, pp. 411-412
PRIMARY OVARIAN NON-HODGKINS-LYMPHOMA - OUTCOME AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY
Authors: DIMOPOULOS MA DALIANI D PUGH W GERSHENSON D CABANILLAS F SARRIS AH
Citation: Ma. Dimopoulos et al., PRIMARY OVARIAN NON-HODGKINS-LYMPHOMA - OUTCOME AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY, Gynecologic oncology, 64(3), 1997, pp. 446-450
INDUCTION OF INTERFERON-INDUCIBLE PROTON-10 BY TUMOR-NECROSIS-FACTOR-ALPHA INTERFERON-GAMMA, BUT NOT BY HTLV-I IS LIKELY TO EXPLAIN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA
Authors: SARRIS AH DALIANI D JACKOW C PUGH W GANSBACHER B CABANILLAS F DUVIC M
Citation: Ah. Sarris et al., INDUCTION OF INTERFERON-INDUCIBLE PROTON-10 BY TUMOR-NECROSIS-FACTOR-ALPHA INTERFERON-GAMMA, BUT NOT BY HTLV-I IS LIKELY TO EXPLAIN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 109(3), 1997, pp. 489-489
THE IP-10-DEPENDENT INHIBITION OF MO7E CELL-GROWTH IS NOT MEDIATED BYAPOPTOSIS
Authors: KLICHE KO ANDREEFF M SARRIS AH
Citation: Ko. Kliche et al., THE IP-10-DEPENDENT INHIBITION OF MO7E CELL-GROWTH IS NOT MEDIATED BYAPOPTOSIS, Blood, 90(10), 1997, pp. 3480-3480
THE NUMBER OF INVOLVED SITES (NIS) PREDICTS FAILURE-FREE SURVIVAL (FFS) FOR ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH ABVD OR EQUIVALENT REGIMENS
Authors: SARRIS AH SANTIAGO M PRETI A MESINA O HAGEMEISTER F MCLAUGHLIN P RODRIGUEZ MA ROMAGUERA J YOUNES A RIGGS S HA C MCBRIDE A PUGH W COX J CABANILLAS F
Citation: Ah. Sarris et al., THE NUMBER OF INVOLVED SITES (NIS) PREDICTS FAILURE-FREE SURVIVAL (FFS) FOR ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH ABVD OR EQUIVALENT REGIMENS, Blood, 90(10), 1997, pp. 3954-3954
INTERLEUKIN-10 PLASMA-LEVELS ARE FREQUENTLY ELEVATED IN MDS AND ACUTEAND CHRONIC MYELOID LEUKEMIAS
Authors: KLICHE KO SARRIS AH ESTEY E SNELL V ANDREEFF M
Citation: Ko. Kliche et al., INTERLEUKIN-10 PLASMA-LEVELS ARE FREQUENTLY ELEVATED IN MDS AND ACUTEAND CHRONIC MYELOID LEUKEMIAS, Blood, 90(10), 1997, pp. 4044-4044
PRIMARY CUTANEOUS NON-HODGKINS-LYMPHOMA (PCNHL) - CLINICAL PRESENTATION AND FAILURE FREE SURVIVAL (FFS) WITH DOXORUBICIN-BASED REGIMENS OR RADIOTHERAPY (RT)
Authors: BRAUNSCHWEIG I SARRIS AH DUVIC M HA C COX J CABANILLAS F
Citation: I. Braunschweig et al., PRIMARY CUTANEOUS NON-HODGKINS-LYMPHOMA (PCNHL) - CLINICAL PRESENTATION AND FAILURE FREE SURVIVAL (FFS) WITH DOXORUBICIN-BASED REGIMENS OR RADIOTHERAPY (RT), Blood, 90(10), 1997, pp. 347-347
PHASE-II STUDY OF TAXOL IN COMBINATION WITH MITOXANTRONE AND IFOSFAMIDE (MINT) WITH CONSOLIDATION ESHAP FOR LYMPHOMAS
Authors: ROMAGUERA J HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA BACHIER C PRETI H SARRIS AH WEBER D YOUNES A CABANILLAS F
Citation: J. Romaguera et al., PHASE-II STUDY OF TAXOL IN COMBINATION WITH MITOXANTRONE AND IFOSFAMIDE (MINT) WITH CONSOLIDATION ESHAP FOR LYMPHOMAS, Blood, 90(10), 1997, pp. 835-835
INTERLEUKIN-10 AS A PROGNOSTIC FACTOR FOR HODGKINS-DISEASE (HD) TREATED WITH ABVD - RESULTS FROM MD-ANDERSON (MDA) AND MAYO-CLINIC (MC)
Authors: SARRIS AH KLICHE KO PEETHAMBARAM PP WITZIG T ANDREEFF M CABANILLAS F
Citation: Ah. Sarris et al., INTERLEUKIN-10 AS A PROGNOSTIC FACTOR FOR HODGKINS-DISEASE (HD) TREATED WITH ABVD - RESULTS FROM MD-ANDERSON (MDA) AND MAYO-CLINIC (MC), Blood, 90(10), 1997, pp. 1495-1495
THE T(2-5)(P23-Q35) IS NOT DETECTABLE IN NORMAL DONOR PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY POLYMERASE CHAIN-REACTION AMPLIFICATION (PCR) OF GENOMIC DNA
Authors: SARRIS AH LUTHRA R KLICHE KO MCBRIDE A ANDREEFF M CABANILLAS F
Citation: Ah. Sarris et al., THE T(2-5)(P23-Q35) IS NOT DETECTABLE IN NORMAL DONOR PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY POLYMERASE CHAIN-REACTION AMPLIFICATION (PCR) OF GENOMIC DNA, Blood, 90(10), 1997, pp. 1496-1496
ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) - PRESENTATION, FAILURE-FREE SURVIVAL (FFS) AND PROGNOSTIC FACTORS WITH DOXORUBICIN-BASED REGIMENS
Authors: SARRIS AH ROMAGUERA J KLICHE KO LUTHRA R SANTIAGO M PUGH W MCBRIDE A ANDREEFF M CABANILLAS F
Citation: Ah. Sarris et al., ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) - PRESENTATION, FAILURE-FREE SURVIVAL (FFS) AND PROGNOSTIC FACTORS WITH DOXORUBICIN-BASED REGIMENS, Blood, 90(10), 1997, pp. 1497-1497
A PREDICTIVE MODEL FOR FAILURE-FREE SURVIVAL (FFS) OF ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH AVBD OR EQUIVALENT REGIMENS
Authors: SARRIS AH PRETI A SMITH T MESINA O SANTIAGO M HAGEMEISTER F MCLAUGHLIN P RODRIGUEZ MA ROMAGUERA J YOUNES A RIGGS S HA C PUGH W MCBRIDE A COX J CABANILLAS F
Citation: Ah. Sarris et al., A PREDICTIVE MODEL FOR FAILURE-FREE SURVIVAL (FFS) OF ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH AVBD OR EQUIVALENT REGIMENS, Blood, 90(10), 1997, pp. 1727-1727
INTERFERON-INDUCIBLE PROTEIN-10 AND THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS
Authors: SARRIS AH DALIANI D ULMER R CROW M BROXMEYER HE PUGH W REISS M CABANILLAS F DEISSEROTH AB DUVIC M
Citation: Ah. Sarris et al., INTERFERON-INDUCIBLE PROTEIN-10 AND THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS, Leukemia & lymphoma, 24(1-2), 1996, pp. 103
Risultati: 1-25 | 26-50 | 51-57